INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Long Term Provisions History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.03 Cr | ₹0.05 Cr |
What is the latest Long Term Provisions ratio of INDO US BIOTECH ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹0.04 Cr |
Mar2023 | ₹0.04 Cr |
Mar2022 | ₹0.04 Cr |
Mar2021 | ₹0.03 Cr |
Mar2020 | ₹0.05 Cr |
How is Long Term Provisions of INDO US BIOTECH Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹0.04 Cr | 2.33 | |
Mar2023 | ₹0.04 Cr | 19.44 | |
Mar2022 | ₹0.04 Cr | 16.13 | |
Mar2021 | ₹0.03 Cr | -40.38 | |
Mar2020 | ₹0.05 Cr | - |
Compare Long Term Provisions of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹308.6 Cr | 1.5% | 1.6% | -27% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,934.7 Cr | -5.8% | -6.3% | 14.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,436.8 Cr | -5.7% | -15.3% | 32.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,264.3 Cr | -1.5% | 0.4% | -16.7% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,435.5 Cr | -2% | -1.8% | -33.7% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹481.8 Cr | 3.5% | 11.2% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | 1.5% |
1.6% |
-27% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses